| 2025-11-06 |
详情>>
股本变动：
变动后总股本5062.31万股
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.46美元,归母净利润-1.27亿美元,同比去年增长27.96%
|
| 2025-11-06 |
财报披露：
美东时间 2025-11-06 盘前发布财报
|
| 2025-10-09 |
详情>>
内部人交易：
Simpson Curran股份减少20811.00股
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-1.26美元,归母净利润-6478.8万美元,同比去年增长44.30%
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益0.12美元,归母净利润608.30万美元,同比去年增长109.61%
|
| 2025-04-08 |
股东大会：
将于2025-05-30召开股东大会
会议内容 ▼▲
- 1.To elect Allan Fox, Alexandra Glucksmann, Ph.D., Curran Simpson and Jennifer Zachary, to serve as Class I directors until the 2028 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2025;
3.To hold an advisory vote on the compensation paid to the Company’s named executive officers;
4.To hold an advisory vote to determine the frequency of future stockholder advisory votes on the compensation paid to the Company’s named executive officers;
5.To approve the REGENXBIO Inc. 2025 Equity Incentive Plan;
6.To transact any other business properly brought before the Annual Meeting and any adjournments or postponements thereof.
|
| 2025-03-13 |
详情>>
业绩披露：
2024年年报每股收益-4.59美元,归母净利润-2.27亿美元,同比去年增长13.81%
|
| 2025-03-13 |
详情>>
业绩披露：
2022年年报每股收益-6.5美元,归母净利润-2.8亿美元,同比去年增长-319.27%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-3.59美元,归母净利润-1.76亿美元,同比去年增长12.31%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益-2.41美元,归母净利润-1.16亿美元,同比去年增长16.16%
|
| 2024-08-01 |
详情>>
业绩披露：
2023年中报每股收益-3.19美元,归母净利润-1.39亿美元,同比去年增长4.25%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益-1.38美元,归母净利润-6333万美元,同比去年增长5.02%
|
| 2024-04-04 |
股东大会：
将于2024-05-31召开股东大会
会议内容 ▼▲
- 1.To elect George Migausky, Kenneth T. Mills and David C. Stump, M.D., to serve as Class III directors until the 2027 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2024;
3.To hold an advisory vote on the compensation paid to the Company’s named executive officers;
4.To transact any other business properly brought before the Annual Meeting and any adjournments or postponements thereof.
|
| 2024-02-27 |
详情>>
业绩披露：
2023年年报每股收益-6.02美元,归母净利润-2.63亿美元,同比去年增长6.00%
|
| 2023-11-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-4.6美元,归母净利润-2.01亿美元,同比去年增长8.98%
|
| 2023-04-06 |
股东大会：
将于2023-06-02召开股东大会
会议内容 ▼▲
- 1.To elect Jean Bennett, M.D., Ph.D., A.N. “Jerry” Karabelas, Ph.D., and Daniel Tassé, to serve as Class II directors until the 2026 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2023;
3.To hold an advisory vote on the compensation paid to the Company’s named executive officers;
4.To transact any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2022-04-07 |
股东大会：
将于2022-06-03召开股东大会
会议内容 ▼▲
- 1.To elect Allan M. Fox and Alexandra Glucksmann, Ph.D., to serve as Class I directors until the 2025 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2022;
3.To hold an advisory vote on the compensation paid to the Company’s named executive officers;
4.To transact any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-19 |
股东大会：
将于2021-06-04召开股东大会
会议内容 ▼▲
- 1.To elect Luke M. Beshar, Kenneth T. Mills and David C. Stump, M.D., to serve as Class III directors until the 2024 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2021;
3.To hold an advisory vote on the compensation paid to the Company’s named executive officers;
4.To approve a proposed amendment to the Company’s Restated Certificate of Incorporation (the “Certificate of Incorporation”) to include a federal forum selection provision;
5.To transact any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-04-08 |
股东大会：
将于2020-05-29召开股东大会
会议内容 ▼▲
- 1.To elect Donald J. Hayden, Jr., A.N. “Jerry” Karabelas, Ph.D., and Daniel Tassé to serve as Class II directors until the 2023 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2020;
3.To hold an advisory vote on the compensation paid to the Company’s named executive officers;
4.To transact any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2019-04-11 |
股东大会：
将于2019-05-31召开股东大会
会议内容 ▼▲
- 1.To elect Daniel J. Abdun-Nabi, Allan M. Fox and Alexandra Glucksmann, Ph.D., to serve as Class I directors until the 2022 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2019;
3.To hold an advisory vote on the compensation paid to the Company’s named executive officers;
4.To hold an advisory vote to determine the frequency of future stockholder advisory votes on the compensation paid to the Company’s named executive officers;
5.To transact any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2018-04-12 |
股东大会：
将于2018-05-25召开股东大会
会议内容 ▼▲
- 1.To elect Luke M. Beshar, Kenneth T. Mills and David C. Stump, M.D., to serve as Class III directors until the 2021 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2018;
3.To transact any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2017-04-13 |
股东大会：
将于2017-05-24召开股东大会
会议内容 ▼▲
- 1.To elect Donald J. Hayden, Jr., A.N. “Jerry” Karabelas, Ph.D. and Daniel Tassé to serve as Class II directors until the 2020 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2017;
3.To transact any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2016-04-18 |
股东大会：
将于2016-06-01召开股东大会
会议内容 ▼▲
- 1.To elect Allan M. Fox and Camille Samuels to serve as Class I directors until the 2019 annual meeting of stockholders;
2.To ratify the selection by the Audit Committee of our Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2016;
3.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|